Literature DB >> 8926107

CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.

M B Purner1, R L Berens, P B Nash, A van Linden, E Ross, C Kruse, E C Krug, T J Curiel.   

Abstract

Both CD4+ and CD8+ cytotoxic T lymphocytes (CTL) are part of the human immune response to Toxoplasma gondii infection. To further our understanding of Toxoplasma immunity, we investigated factors influencing stimulation of CD4+ or CD8+ human T. gondii-specific immune cells. Both antigen-pulsed and Toxoplasma-infected antigen-presenting cells (APC) induced cell proliferation. Toxoplasma-infected APC elicited strong proliferation of CD4+ cells, but little or no proliferation of CD8+ cells, unless high antigen loads were used. Toxoplasma-infected APC stimulated specific cytotoxicity poorly or not at all, owing to death of stimulated cultures, whereas antigen-pulsed APC strongly elicited specific cytotoxicity. Cytotoxicity elicited by either type of APC resided exclusively in CD4+ T cells in polyclonal cultures. Thus, Toxoplasma-infected APC elicited stronger CD4-mediated than CD8-mediated cell proliferation and generated CD4+ CTL more readily than CD8+ CTL. Nonetheless, specific CD8+ memory cells were demonstrated, and rare CD8+ Toxoplasma-specific CTL were subcloned. Fixed Toxoplasma-infected APC (which induce CD8+ CTL) also elicited cell proliferation, but polyclonal cultures stimulated with these infected APC did not die. Unfixed Toxoplasma-infected APC strongly inhibited phytohemagglutinin-induced cell proliferation, whereas fixed APC did not. These data suggested that infected APC were inhibitory or lethal to some immune cells. Further investigations into interactions between immune cells and Toxoplasma-infected cells likely will help elucidate factors involved in the immunopathogenesis of Toxoplasma infection. As other intracellular parasites, including Plasmodium spp. and Leishmania spp., also elicit CD4+ CTL, such work may help establish paradigms governing immunity to intracellular parasites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926107      PMCID: PMC174375          DOI: 10.1128/iai.64.10.4330-4338.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens.

Authors:  J T Wong; R B Colvin
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

2.  HLA antigens in ocular tissues. I. In vivo expression in human eyes.

Authors:  D Abi-Hanna; D Wakefield; S Watkins
Journal:  Transplantation       Date:  1988-03       Impact factor: 4.939

3.  Toxoplasmosis: the time has come.

Authors:  R McCabe; J S Remington
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

4.  A suppressor B lymphocyte inhibiting IL-2 consumption in spleen cell cultures from Mycobacterium bovis BCG-infected mice.

Authors:  R Turcotte
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

5.  Oral infections with Toxoplasma cysts and oocysts in felines, other mammals, and in birds.

Authors:  N L Miller; J K Frenkel; J P Dubey
Journal:  J Parasitol       Date:  1972-10       Impact factor: 1.276

6.  Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain.

Authors:  J S Remington; E N Cavanaugh
Journal:  N Engl J Med       Date:  1965-12-09       Impact factor: 91.245

7.  Major histocompatibility complex molecule expression in the human central nervous system: immunohistochemical analysis of 40 patients.

Authors:  R A Sobel; M B Ames
Journal:  J Neuropathol Exp Neurol       Date:  1988-01       Impact factor: 3.685

8.  Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells.

Authors:  J G Montoya; K E Lowe; C Clayberger; D Moody; D Do; J S Remington; S Talib; C S Subauste
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Intracranial infection in cardiac transplant recipients.

Authors:  R H Britt; D R Enzmann; J S Remington
Journal:  Ann Neurol       Date:  1981-02       Impact factor: 10.422

10.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  20 in total

Review 1.  Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection.

Authors:  L Cristina Gavrilescu; Eric Y Denkers
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 2.  The CD8 T-cell road to immunotherapy of toxoplasmosis.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

3.  A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo.

Authors:  Benjamin J Daniel; Srilakshmi Pandeswara; Michael J Brumlik; Aijie Liu; Suzanne R Thibodeaux; Sara M Ludwig; Xiuhua Sun; Tyler J Curiel
Journal:  J Immunol Methods       Date:  2010-02-08       Impact factor: 2.303

4.  Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.

Authors:  A F Fatoohi; G J N Cozon; T Greenland; J Ferrandiz; J Bienvenu; S Picot; F Peyron
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.

Authors:  Lauren M Staska; Christopher J Davies; Wendy C Brown; Travis C McGuire; Carlos E Suarez; Joo Youn Park; Bruce A Mathison; Jeffrey R Abbott; Timothy V Baszler
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.

Authors:  H V Nielsen; S L Lauemøller; L Christiansen; S Buus; A Fomsgaard; E Petersen
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii.

Authors:  Rajarshi Bhadra; Hongbing Guan; Imtiaz A Khan
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans.

Authors:  S Kahi; G J Cozon; T Greenland; M Wallon; F Gay-Andrieu; F Peyron
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

9.  A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection.

Authors:  T Scorza; S D'Souza; M Laloup; J Dewit; J De Braekeleer; H Verschueren; M Vercammen; K Huygen; E Jongert
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Neospora caninum-infected cattle develop parasite-specific CD4+ cytotoxic T lymphocytes.

Authors:  Lauren M Staska; Travis C McGuire; Christopher J Davies; Harris A Lewin; Timothy V Baszler
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.